ETZ: A Modeling Principle for Confirmability of Drug-Development Studies

Yujia Sun, Yang Han, Xingya Wang +3

Transitioning from Phase 2 to Phase 3 in drug development, at a rate of $\approx$40%, is the most stringent among phase transitions (Hay et al. (2014)). Yet, success rate at Phase…